TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,702 | +35.1% | 1,801 | +33.4% | 0.00% | – |
| Q4 2022 | $2,000 | +100.0% | 1,350 | +69.2% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 798 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 798 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 798 | +6.5% | 0.00% | – |
| Q4 2021 | $3,000 | -62.5% | 749 | -16.8% | 0.00% | – |
| Q3 2021 | $8,000 | +33.3% | 900 | +147.9% | 0.00% | – |
| Q2 2021 | $6,000 | +500.0% | 363 | +725.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 44 | +120.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
| MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
| Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
| Artal Group S.A. | 750,000 | $749 | 0.04% |
| Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
| Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
| X-Square Capital, LLC | 31,919 | $32 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |